1. Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler J.:6.
2. Update on disease-modifying therapies for multiple sclerosis;Vargas;Journal of Investigative Medicine,2017
3. Chapitre 17. Traitements de fond et leurs complications;Vermersch,2017
4. Expenditure, Utilization, and Cost of Specialty Drugs for Multiple Sclerosis in the US Medicaid Population, 2008-2018;Elsisi;Am Health Drug Benefits,2020
5. Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France;Tuppin;Rev Epidemiol Sante Publique,2017